IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6 | -100.0% | 31,800 | -29.3% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | +45.5% | 45,000 | +20.0% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -62.1% | 37,500 | -13.0% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | -63.8% | 43,100 | -32.6% | 0.00% | -50.0% |
| Q4 2021 | $80,000 | +321.1% | 63,900 | +115.2% | 0.00% | +100.0% |
| Q3 2021 | $19,000 | -26.9% | 29,700 | +149.6% | 0.00% | 0.0% |
| Q2 2021 | $26,000 | -76.8% | 11,900 | -46.2% | 0.00% | -83.3% |
| Q1 2021 | $112,000 | – | 22,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 226,916 | $383,488 | 0.76% |
| HARBOURVEST PARTNERS LLC | 335,709 | $567,348 | 0.19% |
| ALLEN HOLDING INC /NY | 687,571 | $1,161,995 | 0.16% |
| ARMISTICE CAPITAL, LLC | 3,476,000 | $5,874,440 | 0.09% |
| Clearwater Capital Advisors, LLC | 394,599 | $666,873 | 0.08% |
| SHEETS SMITH WEALTH MANAGEMENT | 273,879 | $462,856 | 0.07% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $162,972 | 0.06% |
| WEALTH EFFECTS LLC | 53,500 | $90,415 | 0.04% |
| Virtus ETF Advisers LLC | 34,461 | $58,239 | 0.04% |
| FISHMAN JAY A LTD/MI | 162,000 | $273,780 | 0.04% |